These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 10462031

  • 21. Activation of NF kappa B and expression of ICAM-1 in ischemic-reperfused canine myocardium.
    Sun B, Fan H, Honda T, Fujimaki R, Lafond-Walker A, Masui Y, Lowenstein CJ, Becker LC.
    J Mol Cell Cardiol; 2001 Jan; 33(1):109-19. PubMed ID: 11133227
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Nuclear factor-kappaB activation by edema inhibits intestinal contractile activity.
    Uray KS, Wright Z, Kislitsyna K, Xue H, Cox CS.
    Crit Care Med; 2010 Mar; 38(3):861-70. PubMed ID: 20168148
    [Abstract] [Full Text] [Related]

  • 24. The role of protein phosphatases in the expression of inducible nitric oxide synthase in the rat hepatocyte.
    Taylor BS, Liu S, Villavicencio RT, Ganster RW, Geller DA.
    Hepatology; 1999 Apr; 29(4):1199-207. PubMed ID: 10094965
    [Abstract] [Full Text] [Related]

  • 25. Cell proliferation and apoptosis are altered in mice deficient in the NF-kappaB p50 subunit after treatment with the peroxisome proliferator ciprofibrate.
    Tharappel JC, Nalca A, Owens AB, Ghabrial L, Konz EC, Glauert HP, Spear BT.
    Toxicol Sci; 2003 Oct; 75(2):300-8. PubMed ID: 12883078
    [Abstract] [Full Text] [Related]

  • 26. Inhibition of Egr-1 by siRNA in prostate carcinoma cell lines is associated with decreased expression of AP-1 and NF-κB.
    Parra E, Ferreira J, Saenz L.
    Int J Mol Med; 2011 Nov; 28(5):847-53. PubMed ID: 21743958
    [Abstract] [Full Text] [Related]

  • 27. Factors controlling the development of arterial lesions after injury.
    Reidy MA, Fingerle J, Lindner V.
    Circulation; 1992 Dec; 86(6 Suppl):III43-6. PubMed ID: 1424050
    [Abstract] [Full Text] [Related]

  • 28. Expression of I2PP2A, an inhibitor of protein phosphatase 2A, induces c-Jun and AP-1 activity.
    Al-Murrani SW, Woodgett JR, Damuni Z.
    Biochem J; 1999 Jul 15; 341 ( Pt 2)(Pt 2):293-8. PubMed ID: 10393085
    [Abstract] [Full Text] [Related]

  • 29. Tissue factor expression in an animal model of hydronephrosis.
    Wendt T, Zhang YM, Bierhaus A, Kriegsmann J, Deng Y, Waldherr R, Teske T, Luther T, Fünfstück R, Nawroth PP.
    Nephrol Dial Transplant; 1995 Oct 15; 10(10):1820-8. PubMed ID: 8592588
    [Abstract] [Full Text] [Related]

  • 30. Nuclear factor-kappaB activity and arterial response to balloon injury.
    Cercek B, Yamashita M, Dimayuga P, Zhu J, Fishbein MC, Kaul S, Shah PK, Nilsson J, Regnstrom J.
    Atherosclerosis; 1997 May 15; 131(1):59-66. PubMed ID: 9180245
    [Abstract] [Full Text] [Related]

  • 31. Expression of glutathione and gamma-glutamylcysteine synthetase mRNA is Jun dependent.
    Sekhar KR, Meredith MJ, Kerr LD, Soltaninassab SR, Spitz DR, Xu ZQ, Freeman ML.
    Biochem Biophys Res Commun; 1997 May 29; 234(3):588-93. PubMed ID: 9175757
    [Abstract] [Full Text] [Related]

  • 32. Effects of protein phosphatase inhibition by okadaic acid on the differentiation of F9 embryonal carcinoma cells.
    Nishina Y, Sumi T, Iwai SA, Nishimune Y.
    Exp Cell Res; 1995 Apr 29; 217(2):288-93. PubMed ID: 7698228
    [Abstract] [Full Text] [Related]

  • 33. Anti-inflammatory activity of SMP30 modulates NF-κB through protein tyrosine kinase/phosphatase balance.
    Jung KJ, Lee EK, Kim SJ, Song CW, Maruyama N, Ishigami A, Kim ND, Im DS, Yu BP, Chung HY.
    J Mol Med (Berl); 2015 Mar 29; 93(3):343-56. PubMed ID: 25394676
    [Abstract] [Full Text] [Related]

  • 34. Somatostatin inhibits AP-1 function via multiple protein phosphatases.
    Todisco A, Seva C, Takeuchi Y, Dickinson CJ, Yamada T.
    Am J Physiol; 1995 Jul 29; 269(1 Pt 1):G160-6. PubMed ID: 7631795
    [Abstract] [Full Text] [Related]

  • 35. Perivascular delivery of neomycin inhibits the activation of NF-kappaB and MAPK pathways, and prevents neointimal hyperplasia and stenosis after arterial injury.
    García-Trapero J, Carceller F, Dujovny M, Cuevas P.
    Neurol Res; 2004 Dec 29; 26(8):816-24. PubMed ID: 15727265
    [Abstract] [Full Text] [Related]

  • 36. SM-20 is a novel 40-kd protein whose expression in the arterial wall is restricted to smooth muscle.
    Wax SD, Tsao L, Lieb ME, Fallon JT, Taubman MB.
    Lab Invest; 1996 Apr 29; 74(4):797-808. PubMed ID: 8606489
    [Abstract] [Full Text] [Related]

  • 37. Oncogene transformation of PC Cl3 clonal thyroid cell line induces an autonomous pattern of proliferation that correlates with a loss of basal and stimulated phosphotyrosine phosphatase activity.
    Florio T, Scorziello A, Thellung S, Salzano S, Berlingieri MT, Fusco A, Schettini G.
    Endocrinology; 1997 Sep 29; 138(9):3756-63. PubMed ID: 9275062
    [Abstract] [Full Text] [Related]

  • 38. Kinetics of cellular proliferation after arterial injury. V. Role of acute distension in the induction of smooth muscle proliferation.
    Clowes AW, Clowes MM, Fingerle J, Reidy MA.
    Lab Invest; 1989 Mar 29; 60(3):360-4. PubMed ID: 2927077
    [Abstract] [Full Text] [Related]

  • 39. Elevated expression of the cdc25A protein phosphatase in colon cancer.
    Dixon D, Moyana T, King MJ.
    Exp Cell Res; 1998 May 01; 240(2):236-43. PubMed ID: 9596996
    [Abstract] [Full Text] [Related]

  • 40. Protein phosphatase activity in human keratinocytes cultured from normal epidermis and epidermis from patients with harlequin ichthyosis.
    Kam E, Nirunsuksiri W, Hager B, Fleckman P, Dale BA.
    Br J Dermatol; 1997 Dec 01; 137(6):874-82. PubMed ID: 9470902
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.